Infanrix Hexa Vaccine

Introduction

Infanrix Hexa is a combination vaccine that provides protection against several infectious diseases. It contains the following active ingredients:

• Diphtheria Toxoid
• Tetanus Toxoid
• Pertussis Toxoid
• Filamentous Haemagglutinin
• Pertactin
• Hepatitis B Vaccine
• Poliomyelitis Virus Type 1
• Poliomyelitis Virus Type 2
• Poliomyelitis Virus Type 3
• Haemophilus Influenzae Type B Capsular Polysaccharide

Uses

Infanrix Hexa is indicated for the prevention of diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio), and Haemophilus influenzae type B infections. It is commonly administered as a routine vaccination in infants and young children, as well as in certain at-risk populations.

Dosage and Administration

The vaccine is administered via intramuscular injection. The specific dosage and administration schedule may vary depending on the age and health status of the individual. It is typically given in a series of doses, with booster shots recommended at certain intervals. Follow the guidance of a healthcare professional to ensure the appropriate dosage and timing.

Mechanism of Action

Infanrix Hexa works by stimulating the immune system to produce protective antibodies against the targeted infectious agents. Each component of the vaccine elicits an immune response, helping the body recognize and fight off the diseases it is designed to protect against. By introducing harmless fragments or inactivated forms of the pathogens, the vaccine prepares the immune system to mount a strong defense if exposed to the actual infectious agents in the future.

Side Effects

Common side effects of Infanrix Hexa may include:

• Redness, swelling, or pain at the injection site
• Mild fever
• Fatigue or drowsiness
• Irritability or fussiness in infants

Serious side effects are rare but may include severe allergic reactions. If you experience any unusual or severe symptoms after receiving the vaccine, seek immediate medical attention.

Drug Interactions

Infanrix Hexa may interact with certain medications or substances. Inform your healthcare provider about any other vaccines, medications, or supplements you are taking before receiving the vaccine. They can provide guidance on any potential interactions and adjust the vaccination schedule if necessary.

Precautions

Before receiving Infanrix Hexa, inform your healthcare provider if you have a history of severe allergic reactions to any vaccine components or if you have any medical conditions that may affect the administration of the vaccine. Some precautions to consider include:

• History of Guillain-Barré syndrome
• Immunosuppressive therapy
• Pregnancy or breastfeeding

Your healthcare provider will assess your individual circumstances and determine whether Infanrix Hexa is suitable for you.

Storage

Patient Tips

• follow the recommended vaccination schedule and complete the full series of doses to ensure optimal protection.
• If you miss a scheduled dose, consult your healthcare provider for guidance on the next steps.
• Keep a record of your vaccination history for future reference.
• Report any side effects or adverse reactions to your healthcare provider.
• In case of an emergency, such as a severe allergic reaction (anaphylaxis), seek immediate medical attention.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Vaccinations (NHS UK) [Accessed 8 Jun. 2024] (online) Available at:
• Dukoral suspension and effervescent powder for oral suspension, Cholera vaccine (inactivated, oral) (Health Professionals SmPC) Available at:
• Cholera Vaccine Dosage Guide + Max Dose, Adjustments (Drugs.com) [Accessed 27 Jun. 2024] (online) Available at:
• cholera vaccine, live suspension for reconstitution (RX) [Accessed 26 Jun. 2024] (online) Available at:
• Cholera Vaccine (MedlinePlus) [Accessed 25 Jun. 2024] (online) Available at:
• Sit B, Fakoya B, Waldor MK. Emerging Concepts in Cholera Vaccine Design. Annu Rev Microbiol. 2022 Sep 8;76:681-702. doi: 10.1146/annurev-micro-041320-033201. Epub 2022 Jun 27. [Accessed 2 Jun. 2024] Available at: